Where:
The Westin Copley Place, Boston
10 Huntington Avenue
Boston, MA 02116
Admission:
$Earlybird: USD 1999.0, Standard: USD 2899.0
Categories:
Lectures & Conferences
Event website:
https://go.evvnt.com/492574-0?pid=5248
In the context of unprecedented gene therapy clinical progress and mounting regulatory scrutiny, the inaugural Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency, quality and safety of gene therapy products.
Focused specifically on addressing the unique analytical challenges posed by gene therapy vectors, this technical scientific meeting will unite the ‘boots on the ground’ scientists grappling with these challenges first-hand.
Delving into technical analytics to assess potency, capsid integrity, empty vs full capsids and viral titers of AAV and lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative novel tools to support safe and effective gene therapy development.
URLs:
Tickets: https://go.evvnt.com/492574-1?pid=5248
Brochure: https://go.evvnt.com/492574-3?pid=5248
Speakers: Peter Marks, FDA, Svetlana Bergelson, Biogen, Wei-Chiang Chen, Solid Biosciences, Win Den Cheung, REGENXBIO, Vivian Choi, Takeda, Pete Clarner, Biogen, Jeffrey Glenn, Spark Therapeutics, Russell Goetze, Bluebird Bio, Joseph Lee, PTC Therapeutics, Lawrence Thompson, Pfizer, Zichuan Zhang, Sanofi, Fengrong Zuo, AveXis, Ales Strancar, BIA Separations, David Malliaros, Ultragenyx
Sunday, Jul 20, 2025 11:30a
Crane Beach
Monday, Jul 28, 2025 6:30p
WBUR CitySpace
Sunday, Jul 13, 2025 11:00a
The Muddy River at the Ipswich Street Bridge
Saturday, Aug 02, 2025 goes until 08/03
Downtown New Bedford